ACT Genomics Overview
- Founded
-
2014
- Status
-
Private
- Latest Deal Type
-
Series D
- Investors
-
12
ACT Genomics General Information
Description
Provider of cancer molecular information services designed to rewrite the existing model of diagnostic, treatment, and monitoring. The company's cancer molecular information services implement next-generation sequencing and multiplex molecular testing, coupled with bioinformatics tools, curated proprietary databases and data visualization technologies, enabling oncologists to address the key challenges in cancer treatments.
Contact Information
Website
www.actgenomics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Services
Other Industries
Biotechnology
Primary Office
- 3 Floor, Number 345
- Xinhu 2nd Road
- Taipei City, Neihu District 114
- Taiwan
+886 02 0000 0000
ACT Genomics Timeline
ACT Genomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series D) | 17-Dec-2020 | 0000 | Completed | Profitable | ||
| 3. Early Stage VC | 26-Sep-2018 | 000.00 | 0000 | Completed | Startup | |
| 2. Early Stage VC (Series B) | 01-May-2016 | $12.5M | $20.5M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 13-Feb-2015 | $8M | $8M | Completed | Startup |
ACT Genomics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of cancer molecular information services designed to rewrite the existing model of diagnostic, treatment, and m
Other Healthcare Services
Taipei City, Taiwan
0000
00000000000
0000
000000
por incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation
0000000000000
South Plainfield, NJ
000
As of 0000
0000
0000-00-00
000000&0
000000
p ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dol
0000000000 00000000 (0000000000)
Cambridge, United Kingdom
Add Comparison
ACT Genomics Competitors (20)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genewiz | Formerly VC-backed | South Plainfield, NJ | 000 | 000000&0 | ||
| 0000000000 | Corporation | Cambridge, United Kingdom | ||||
| 00000 00000000 | Private Equity-Backed | Aliso Viejo, CA | 000 | 000000&0 | ||
| 00000 000000 00000 | Venture Capital-Backed | Nashik, India | 000 | 00000 | 0000000000 0 | 00000 |
| 000000000 00000000 | Formerly VC-backed | Billerica, MA | 00 | 00000 | 000000&0 | 00000 |
ACT Genomics Executive Team (6)
ACT Genomics Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Aflac Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| Drive Catalyst | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| JAFCO Asia | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Kyoto University Innovation Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| CLSA Capital Partners | PE/Buyout | Minority | 000 0000 | 000000 0 |
ACT Genomics Investments & Acquisitions (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000 0000000 | 24-Aug-2021 | 00000 0000 | Laboratory Services (Healthcare) | 000 00000 | |
| 00 0000000000 | 06-Jul-2021 | 0000000000 | Biotechnology | 000 00000 | |
| ACTmed | 01-Mar-2017 | Joint Venture | Biotechnology |
ACT Genomics Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 00 00000000000 | Biotechnology | Rhyl, United Kingdom | 0000 |